Repligen Corp - Company Profile
Powered by 
All the data and insights you need on Repligen Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Repligen Corp Strategy Report
- Understand Repligen Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Repligen Corp (Repligen) is a life science company that develops and commercializes bioprocessing technologies for the manufacturing of biological drugs. Its products include upstream and downstream filtration, chromatography products, fluid management, cell culture supplements, ligands, and operating room disposables. The company also provides solutions to overcome the development and production of modalities into a new class of drugs. Its services comprise hands-on-process and implementation consultation services. It has an operational presence in Sweden, the Netherlands, Germany, France, Ireland, India, South Korea, China, Japan, Singapore, and the US. Repligen is headquartered in Waltham, Massachusetts, the US.
Headquarters
United States of America
Address
Building 1, Suite 100, 41 Seyon Street, Waltham, Massachusetts, 02453
Website
www.repligen.com
Telephone
1 781 2500111
No of Employees
1,783
Industry
Medical Equipment
Ticker Symbol & Exchange
RGEN (NASD)
Revenue (2022)
$638.8M
-20.3%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-77.6%
(2022 vs 2021)
Market Cap*
$9.0B
Net Profit Margin (2022)
XYZ
-71.9%
(2022 vs 2021)
* As of and is in US$
Repligen Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Products | OPUS |
| Upstream Filtration Products | XCell |
| Downstream Filtration Products | TangenX |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Products/Services | In November, the company launched TangenX SC. |
| 2023 | Contracts/Agreements | In September, the company entered into an agreement to acquire Metenova AB. |
| 2023 | New Products/Services | In August, the company and Sartorius launched an integrated bioreactor system. |
Competitor Comparison
| Key Parameters | Repligen Corp | Neurocrine Biosciences Inc | Fortress Biotech Inc | Axim Biotechnologies Inc | biosyn Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Waltham | San Diego | Bay Harbor Islands | San Diego | Carlsbad |
| State/Province | Massachusetts | California | Florida | California | California |
| No. of Employees | 1,783 | 1,400 | 186 | 6 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Karen A. Dawes | Chairman | Executive Board | 2005 | 71 |
| Tony J. Hunt | Director; Chief Executive Officer | Executive Board | 2015 | 59 |
| Jason K. Garland | Chief Financial Officer | Senior Management | 2023 | - |
| James R. Bylund | Chief Operating Officer | Senior Management | 2022 | 60 |
| Keith Lee Robinson | Chief Information Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward